BIOMAT Database Logo BIOMAT Database Logo

Synthesis of 1- and 3-(1-substituted 4-piperidinyl)-1,2,3,4-tetrahydro-2-oxoquinazolines as potential antihypertensive agents. 1985

H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima

UI MeSH Term Description Entries
D008297 Male Males
D010880 Piperidines A family of hexahydropyridines.
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima
Studies on the medicinal chemistry of oxoquinazolines. XI. Synthesis of 1-methyl-3-substituted 1,2,3,4-tetrahydro-4-oxoquinazolines.
December 1971, Acta pharmaceutica Suecica,
H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima
Efficient synthesis of 2-substituted 2,3-dihydro-4-quinolones as potential intermediates for 2-substituted 1,2,3,4-tetrahydro-4-quinolone antitumor agents.
May 2006, Archives of pharmacal research,
H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima
Synthesis and evaluation of 3-substituted 1-[4-(2-indol-3-ylethyl)piperazinyl]ureas as potential antihypertensive agents.
December 1978, Journal of pharmaceutical sciences,
H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima
Synthesis of 1-substituted carbazolyl-1,2,3,4-tetrahydro- and carbazolyl-3,4-dihydro-β-carboline analogs as potential antitumor agents.
February 2011, Marine drugs,
H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima
Antitumor agents. 181. Synthesis and biological evaluation of 6,7,2',3',4'-substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents.
March 1998, Journal of medicinal chemistry,
H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima
Studies on the medicinal chemistry of oxoquinazolines.3. 1-(omega-dimethylamino)alkyl derivatives of 3-substituted 1,2,3,4-tetrahydro-2,4-dioxoquinazolines.
June 1969, Acta pharmaceutica Suecica,
H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima
Synthesis and pharmacological properties of some 2-substituted 1-(3-pyridyl)-1,2,3,4-tetrahydro-beta-carbolines.
January 1987, Polish journal of pharmacology and pharmacy,
H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima
Synthesis of 3-(4-acylaminopiperazin-1-ylalkyl)indoles as potential antihypertensive agents.
November 1977, Journal of medicinal chemistry,
H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima
Antihypertensive agents. 3. Synthesis and antihypertensive activity of 3-(4-(p-fluoro-phenyl)-1,2,3,6-tetrahydro-1-pyridyl)-1-(1-(2-hydroxyethyl)-5-methyl-4-pyrazolyl)-1-propanone.
October 1971, Experientia,
H Takai, and H Obase, and N Nakamizo, and M Teranishi, and K Kubo, and K Shuto, and Y Kasuya, and K Shigenobu, and M Hashikami, and N Karashima
Synthesis of 1,2,3,4-tetrahydro-beta-carboline derivatives as hepatoprotective agents. II. Alkyl 1,2,3,4-tetrahydro-beta-carboline-2-carbodithioates.
August 1987, Chemical & pharmaceutical bulletin,
Copied contents to your clipboard!